Search

Search Constraints

You searched for: Author/Creator Okusaka, T.

Search Results

1. 2337 Ramucirumab (RAM) as a second-line treatment in patients with advanced hepatocellular carcinoma (HCC) following first-line therapy with sorafenib in the randomized phase III REACH study: Analysis of alpha-fetoprotein (AFP) kinetics during treatment. (September 2015)

2. 2356 Phase I dose-escalation study of nintedanib in Japanese patients with advanced hepatocellular carcinoma (HCC) and mild or moderate liver impairment. (September 2015)

3. 2382 A proof-of-concept study of MEK inhibitor trametinib monotherapy in patients with biliary tract cancers. (September 2015)

4. 409 Plasma biomarker for detection of early stage pancreatic cancer and risk factors for pancreatic malignancy using antibodies against apolipoprotein-AII isoforms. (September 2015)

5. First-in-man phase 1 study of TAS-114 in combination with S-1 in Japanese patients with advanced solid tumors. (December 2016)